Pomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL
Clinical trial NCT07072208 · RECRUITING
Trial details
- NCT number
- NCT07072208
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-01
- Primary completion
- 2027-05-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.